scorecardresearch
Add as a preferred source on Google
Wednesday, November 5, 2025
TopicMedicines

Topic: Medicines

India’s import of China-made medicines has increased 50 per cent in 4 years

The export of pharmaceuticals, especially generics and drug formulations, is one of India’s strengths. But China has been steadily eroding India’s advantage.

After chief’s transfer, govt wants to turn drug price regulator into ‘market research agency’

The NPPA was behind capping the prices of knee implants, stents and medicines.

Audit smells a scam in affordable drugs scheme: Medicines sold above MRP, rules flouted

Govt’s internal auditor slaps department running the jan aushadhi scheme with charges of misappropriation, excess spending, and low quality control.

On Camera

India’s think tanks double up as lobbyists, give no disclosures. Hurt policymaking

Many 'independent' reports, intended to shape policies, are sponsored by industry groups or entities with deep pockets and vested interests. This process must become transparent.

India may cancel green projects struggling to find clients

While the move could free up grid capacity struggling to keep up with rapid renewable rollout, it would be a major setback for green ambitions. India aims to double clean power capacity to 500 gigawatts by the end of the decade.

India & Israel ink agreement to share, co-develop & co-produce advanced defence tech

Agreement signed during 17th Joint Working Group (JWG) on defence cooperation. Defence Secretary Rajesh Kumar Singh met Director General in Israeli Ministry of Defence Amir Baram Tuesday. 

Trump’s trade wars have rewritten powerplay, but India didn’t get the memo

This world is being restructured and redrawn by one man, and what’s his power? It’s not his formidable military. It’s trade. With China, it turned on him.